These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4157354)

  • 1. Post-exposure prophylaxis of murine rabies with polyinosinic-polycytidylic acid and chlorite-oxidized amylose.
    Harmon MW; Janis B; Levy HB
    Antimicrob Agents Chemother; 1974 Oct; 6(4):507-11. PubMed ID: 4157354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus entry inhibition by chlorite-oxidized oxyamylose versus induction of antiviral interferon by poly(I:C).
    Li S; Martens E; Dillen C; Van den Steen PE; Opdenakker G
    Biochem Pharmacol; 2008 Oct; 76(7):831-40. PubMed ID: 18703022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorite-oxidized amylose as an adjuvant for interferon production.
    Levy HB; Duenwald J; Buckler CE
    Infect Immun; 1973 Mar; 7(3):457-60. PubMed ID: 4713694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antiviral antibodies in resistance against coxsackievirus B3 infection: interaction between preexisting antibodies and an interferon inducer.
    Cho CT; Feng KK; McCarthy VP; Lenahan MF
    Infect Immun; 1982 Aug; 37(2):720-7. PubMed ID: 6288570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies vaccines and interferon.
    Turner GS
    J Hyg (Lond); 1972 Sep; 70(3):445-53. PubMed ID: 4506993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of murine rabies after exposure: efficacy of polyriboinosinic-polyribocytidylic acid alone and in combination with three rabies vaccines.
    Harmon MW; Janis B
    J Infect Dis; 1975 Sep; 132(3):241-9. PubMed ID: 1159327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpesvirus hominis infection in newborn mice: treatment with interferon inducer polyinosinic-polycytidylic acid.
    Kern ER; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1975 Jun; 7(6):793-800. PubMed ID: 1155920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis.
    Stringfellow DA; Overall JC; Glasgow LA
    J Infect Dis; 1974 Nov; 130(5):470-80. PubMed ID: 4371528
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice.
    Wong JP; Saravolac EG; Sabuda D; Levy HB; Kende M
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2574-6. PubMed ID: 8585749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose.
    Talmadge JE; Adams J; Phillips H; Collins M; Lenz B; Schneider M; Chirigos M
    Cancer Res; 1985 Mar; 45(3):1066-72. PubMed ID: 3971361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine.
    Baer GM; Moore SA; Shaddock JH; Levy HB
    Bull World Health Organ; 1979; 57(5):807-13. PubMed ID: 120234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of interferon in prophylaxis of rabies after exposure.
    Wiktor TJ; Koprowski H; Mitchell JR; Merigan TC
    J Infect Dis; 1976 Jun; 133 Suppl():A260-5. PubMed ID: 819599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on rabies postexposure prophylaxis in mice: a comparison of vaccine with interferon and vaccine.
    Moreno JA; Baughcum SD; Levy HB; Baer GM
    J Gen Virol; 1979 Jan; 42(1):219-22. PubMed ID: 759557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biphasic modulation of acetaminophen bioactivation and hepatotoxicity by pretreatment with the interferon inducer polyinosinic-polycytidylic acid.
    Kalabis GM; Wells PG
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1408-19. PubMed ID: 2262910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of extablished Friend virus leukemia by statolon: potentiation of statolon's leukemosuppressive activity by chlorite-oxidized oxyamylose.
    Weislow OS; Wheelock EF
    Infect Immun; 1975 Jan; 11(1):129-36. PubMed ID: 1090523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of a murine cytomegalovirus infection with exogenous interferon, polyinosinic-polycytidylic acid, and polyinosinic-polycytidylic acid-poly-L-lysine complex.
    Kern ER; Olsen GA; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1978 Feb; 13(2):344-6. PubMed ID: 206203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents.
    Stringfellow DA; Glasgow LA
    Infect Immun; 1972 Nov; 6(5):743-7. PubMed ID: 4344367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of treatment with exogenous interferon, polyinosinic acid-polyctyidylic acid or polyinosinic acid-polycytidylic acid-poly-L-lysine complex on encephalomyocarditis virus infections in mice.
    Olsen GA; Kern ER; Glasgow LA; Overall JC
    Antimicrob Agents Chemother; 1976 Oct; 10(4):668-76. PubMed ID: 185951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of a modified polyinosinic acid--polycytidylic acid complex against herpes simplex keratitis in monkeys (author's transl)].
    Teranishi H
    Nippon Ganka Gakkai Zasshi; 1980 Sep; 84(9):1198-204. PubMed ID: 7223554
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.
    Stringfellow DA
    Antimicrob Agents Chemother; 1977 Jun; 11(6):984-92. PubMed ID: 879763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.